Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
Blood p-tau 181 is sensitive for identifying clinically diagnosed AD patients in the very early disease stages; differentiates AD from other neurodegenerative diseases and predict cognitive decline and hippocampal atrophy.
Read more here.
